Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Lawrence Atinsky

Lawrence Atinsky is a Partner and joined the Firm in 2013. Mr. Atinsky focuses on structuring investments in Deerfield’s Private Design Funds, as well as other Deerfield Funds. Mr. Atinsky has over 25 years of experience structuring and negotiating public and private financings, strategic transactions and licensing arrangements involving healthcare companies. Prior to joining Deerfield, Mr. Atinsky served as a Partner and General Counsel of Ascent Biomedical Ventures, a venture capital firm investing in healthcare companies. Since 2000, he has been the General Counsel of several private companies in the healthcare industry and is actively involved in the operations of many early-stage companies. Mr. Atinsky began his career as an associate in the Mergers & Acquisitions department at the law firm of Skadden Arps LLP. He holds a B.A. with high distinction from the University of Wisconsin and a J.D. from New York University School of Law.